No Detail Found!

Effects of lithium carbonate combined with olanzapine on glucose and lipid metabolism in the treatment of bipolar disorder and gender differences

Author(s)
Ningbo Yang Department of Psychiatry, The First Affiliated Hospital of Henan University of Science and Technology,Luoyang City, Henan Province,
Jie Li Department of Emergency Medicine, the First Affiliated Hospital of Henan University of Science and Technology,Luoyang City, Henan Province,
Hongxia Hu Department of Clinical Laboratory Medicine, the First Affiliated Hospital of Henan University of Science and Technology,Luoyang City, Henan Province,
Xujiang Wang Centre for Psychological Heath Education of Henan University of Science and Technology,Luoyang City, Henan Province,
Shaoli Shi Department of Psychiatry, the Fifth People's Hospital of Luoyang,Luoyang City, Henan Province,
Abstract
To explore the effect of lithium carbonate combined with olanzapine on glucose and lipid metabolism, as well as gender differences in treating bipolar disorder (BD). 110 BD patients admitted to the Fifth People's Hospital of Luoyang from February 2022 to January 2024 were retrospectively included in the study. Patients were categorized into two groups based on treatment: the single group (lithium carbonate, n = 50) and the coalition group (lithium carbonate + olanzapine, n=60). Post-treatment, the coalition group's YMRS score was 4.67±1.34 points and BRMS score was 24.93±2.30 points, both lower than the single group's YMRS score of 7.64±1.51 points and BRMS score of 34.38±2.30 points (P<0.05). The coalition group's effective rate was 96.67%, significantly higher than the single group's 82.00% (P<0.05). Post-treatment, the coalition group had lower levels of FBG, TC, TG and LDL-C than the single group, while HDL-C was higher (P<0.05). Additionally, glycolipids levels in both male and female subgroups increased posttreatment compared to pre-treatment. The efficacy of lithium carbonate sustained-release tablets combined with olanzapine in the treatment of bipolar disorder (BD) is well-established. This combination therapy can effectively alleviate manic and psychiatric symptoms, enhance patients' social functioning and improve their quality of life. Furthermore, it has a minimal impact on glucose and lipid metabolism, with no observed gender differences.
Publication Details
Page(s) 1365-1373
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
Olanzapine, Bipolar disorder, sex difference, glycolipid metabolism, lithium carbonate
References
Arnold I,Dehning J,Grunze A,Hausmann A .2021 .Old age bipolar disorder-epidemiology, aetiology and treatment. Medicina (Kaunas), 57(6) : 587.
Belancic A,Pavesic Radonja A,Ganoci L,Vitezic D,Božina N D .2024 .Challenging pharmacotherapy management of a psychotic disorder due to a delicate pharmacogenetic profile and drug-drug interactions: A case report and literature review. Croat. Med, 65(4) : 383-395.
Cai R,Huang C,Ni L,Liu Z,Zhang S,Qiu Y,Hu J,Gao J,Yu M,Tang X,Zhou C,Zhang X,Zhang X,Fang X .2023 .The motivation and pleasure deficits but not expressivity affects social functioning through cognitive function in male patients with schizophrenia: A structural equation model. Asian. J. Psychiatr., 85 : 103616.
Cavieres A,Acuña V,Arancibia M,Lopetegui N M .2023 .Differences in social perception in people with schizophrenia and bipolar disorder. Schizophr. Res. Cogn., 33 : 100286.
Cohen M,Lima AFBDS,Silva CPA,Miguel SRPS,Fleck MPA .2022 .Quality of life of family primary caregivers of individuals with bipolar disorder and schizophrenia in south of Brazil. Int. J. Soc. Psychiatry., 68(4) : 818-826.
Corrao MM,Nelson LA .2022 .Olanzapine/ Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain. CNS. Drugs, 36(6) : 605-616.
de Groot T,Ebert LK,Christensen BM,Andralojc K,Cheval L,Doucet A,Mao C,Baumgarten R,Low BE,Sandhoff R,Wiles MV,Deen PMT,Korstanje R .2019 .Identification of Acer2 as a first susceptibility gene for lithium-induced nephrogenic diabetes insipidus in mice. J. Am. Soc. Nephrol., 30(12) : 2322-2336.
Ezzaher A,Haj MD,Mechri A,Neffati F,Douki W,Gaha L,Najjar MF .2011 .Metabolic syndrome in Tunisian bipolar I patients. , 11(3) : 414-20.
Falgas-Bague I,Cruz-Gonzalez M,Zhen-Duan J,Nagendra A,Alvarez K,Canino G,Duarte CS,Bird H,M De-Salazar P,Alegría M .2023 .Association of sociocultural stressors with bipolar disorder onset in Puerto Rican youth growing up as members of a minoritized ethnic group: Results from the Boricua Youth Longitudinal Study. Lancet. Reg. Health. Am., 24 : 100549.
Fang M,Fan Z,Liu S,Feng S,Zhu H,Yin D,Jia H,Wang G .2023 .Preventive interventions for individuals at risk of developing bipolar disorder: A systematic review and meta-analysis. J. Affect. Disord., 340 : 53-63.
Fountoulakis KN,Tohen M,Zarate CA .2022 .Lithium treatment of bipolar disorder in adults: A systematic review of randomized trials and metaanalyses. Eur. Neuropsychopharmacol., 54 : 100-115.
Ghaemi SN,Angst J,Vohringer PA,Youngstrom EA,Phelps J,Mitchell PB,McIntyre RS,Bauer M,Vieta E,Gershon S E .2022 .Clinical research diagnostic criteria for bipolar illness (CRDC-BP): Rationale and validity. Int. J. Bipolar. Disord., 10(1) : 23.
Haddad HW,Boardman E,Williams B,Mouhaffel R,Kaye AM,Kaye AD .2022 .Combination olanzapine and samidorphan for the management of schizophrenia and bipolar 1 disorder in adults: A narrative review. Health Psychol. Res., 10(3) : 34224.
Han K,Cui J,Chen S,Yu T .2023 .Effects of olanzapine and lithium carbonate antipsychotic agents on dopamine oxidation. , 148(14) : 3330-3340.
He Y,Gan X,Li X,Wang T,Li J,Lei T,Huang Y,Liu R,Chen F,Teng T,Xie Y,Ouyang X,Zhou X. . .Sequenced treatment alternatives to relieve adolescent depression (STAR-AD): A multicentre open-label randomized controlled trial protocol. BMC. Psychiatry, 23(1) : 789.
Hofmann AB,Schmid HM,Jabat M,Brackmann N,Noboa V,Bobes J,Garcia-Portilla MP,Seifritz E,Vetter S,Egger ST .2022 .Utility and validity of the Brief Psychiatric Rating Scale (BPRS) as a transdiagnostic scale. Psychiatry. Res., 314 : 114659.
Joshi MB,Pai S,Balakrishnan A,Bhat M,Kotambail A,Sharma P,Satyamoorthy K P .2019 .Evidence for perturbed metabolic patterns in bipolar disorder subjects associated with lithium responsiveness. Psychiatry. Res., 273 : 252-259.
Kahn RS,Kane JM,Correll CU,Arevalo C,Simmons A,Graham C,Yagoda S,Hu B,McDonnell D B .2023 .Olanzapine/samidorphan in young adults with schizophrenia, schizophreniform disorder, or bipolar I disorder who are early in their illness: Results of the randomized, controlled ENLIGHTEN-Early Study. J. Clin. Psychiatry, 84(3) : 22m14674.
Kim H,Yoo J,Han K,Park MJ,Kim HS,Baek J,Jeon HJ .2022 .Female reproductive factors are associated with the risk of newly diagnosed bipolar disorder in postmenopausal women. J. Psychiatr. Res., 153 : 82-89.
Köhler-Forsberg O,Sylvia LG,Thase M,Calabrese JR,Tohen M,Bowden CL,McInnis M,Iosifescu DV,Kocsis JH Friedman ES,Ketter TA,McElroy SL,Shelton RC,Fung V,Ostacher MJ,Nierenberg AA,Psychiatry Z. J. .2023 .Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes. , 57(1) : 93-103.
Kong L,Wang H,Yan N,Xu C,Chen Y,Zeng Y,Guo X,Lu J,Hu S J .2024 .Effect of antipsychotics and mood stabilisers on metabolism in bipolar disorder: A network meta-analysis of randomised-controlled trials. EClinical Medicine, 71 : 102581.
Korosec Hudnik L,Blagus T,Redenšek Trampuž S,Dolzan V,Bon J,Pjevac M .2024 .Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics. Front. Psychiatry, 15 : 1363051.
Lemvigh CK,Karantonis JA,Furlong LS,Carruthers SP,Pantelis C,Rossell SL,Van Rheenen TE SL .2022 .Characterization and interrelationships of theory of mind, socially competitive emotions and affective empathy in bipolar disorder. Br. J. Clin. Psychol, 61(1) : 76-92.
Lin S,Liu R,Zhang Z,Liu F,Qin S,Wei Y,Wang F Y .2023 .Sex-specific immune-inflammatory markers and lipoprotein profile in patients with anhedonia with unipolar and bipolar depression. BMC Psychiatry, 23(1) : 879.
Monahan C,McCoy L,Powell J,Gums JG .2022 .Olanzapine/samidorphan: New drug approved for treating bipolar i disorder and schizophrenia. , 56(9) : 1049-1057.
Nestsiarovich A,Gaudiot CES,Baldessarini RJ,Vieta E,Zhu Y,Tohen M Y .2022 .Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials. Eur. Neuropsychopharmacol., 54 : 75-89.
Nierenberg AA,Harris MG,Kazdin AE,Puac-Polanco V,Sampson N,Vigo DV,Chiu WT,Ziobrowski HN,Alonso J,Altwaijri Y,Borges G,Bunting B,Caldas-deAlmeida JM,Haro JM,Hu CY,Kiejna A,Lee S,McGrath JJ,Navarro-Mateu F,Posada-Villa J,Scott KM,Stagnaro JC,Viana MC,Kessler RC .2021 .Perceived helpfulness of bipolar disorder treatment: Findings from the World Health Organization World Mental Health Surveys. and WHO World Mental Health Survey Collaborators, 23(6) : 565-583.
Pahwa M,Kucuker MU,Ho MC,Puspitasari A,Moore KM,Betcher HK,Frye MA,Singh B,Ozerdem A,Veldic M .2023 .Cardiometabolic and endocrine comorbidities in women with bipolar disorder: A systematic review. J. Affect. Disord., 323 : 841-859.
Qiu Y,Li S,Teng Z,Tan Y,Xu X,Yang M,Zhao Z,Liu J,Tang H,Xiang H,Chen J,Wang B,Wu H B .2022 .Association between abnormal glycolipid level and cognitive dysfunction in drug-naïve patients with bipolar disorder. J. Affect. Disord., 297 : 477-485.
Samara MT,Levine SZ,Leucht S SZ .2023 .Linkage of young mania rating scale to clinical global impression scale to enhance utility in clinical practice and research trials. Pharmacopsychiatry, 56(1) : 18-24.
Sun L,Yagoda S,Yao B,Graham C,von Moltke L C .2019 .Combination of olanzapine and samidorphan has no clinically significant effect on the pharmacokinetics of lithium or valproate. Clin. Drug Investig, 40(1) : 55-64.
Toledo FGS,Martin WF,Morrow L,Beysen C,Bajorunas D,Jiang Y,Silverman BL,McDonnell D,Namchuk MN,Newcomer JW,Graham C .2022 .Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: Exploratory phase 1 results in healthy volunteers. , 47(3) : 696-703.
Tomasik J,Harrison SJ,Rustogi N,Olmert T,BartonOwen G,Han SYS,Cooper JD,Eljasz P,Farrag LP,Friend LV,Bell E,Cowell D,Bahn S D .2024 .Metabolomic biomarker signatures for bipolar and unipolar depression. JAMA. Psychiatry, 81(1) : 101-106.
Uwai Y,Nabekura T Y .2022 .Analysis of adverse drug events in patients with bipolar disorders using the Japanese adverse drug event report database. Pharmazie, 77(7) : 255-261.
Yang Y,Liu W,Wu R .2024 .Effects of CYP2D6 gene polymorphism on plasma concentration and therapeutic effect of olanzapine. , 10(7) : e28832.
0

Citations

0

Downloads

51

Views